Document Detail

MedLine Citation:
PMID:  22360415     Owner:  NLM     Status:  Publisher    
Introduction: The metallic ureteral stent was first developed for patients with ureteral obstruction related to malignant disease, but it can be used in all patients requiring chronic indwelling ureteral stents, including those with benign disease. The traditional method of polymer stent management often requires multiple exchanges per year depending upon patient and logistical factors. This has significant direct financial cost and likely a negative effect on patients' overall health. Objective: To analyze and compare the costs associated with chronic indwelling metal and traditional ureteral stents. Methods: A prospective database of patients undergoing metal stent placement from February 2008 to June 2010 was reviewed. Mean charges for a single traditional non-metal and metal stent insertion were calculated. Charges were based on direct hospital charges related to stent cost and surgery. Cost data was based on the fiscal year 2010 cost for polymer or metal stent insertions. Results: 21 patients underwent metal stent placement at our institution. Of these, 3 traditional stent placements were omitted from analysis due to bundled charges for ureteroscopy at the same setting. Mean charges per single traditional and metal stent placement were $6,072.75 and $9,469.50, respectively. The estimated annual charges for traditional stents (3-6 exchanges) would be $18,218.25 to $36,436.50. Compared to metal stents this is a potential financial savings of 48% to 74%. The mean cost to patients was 21.6% and 25.4% of the charges for metal and polymer stents respectively. No patient required early discontinuation of his or her metal stent due to LUTS or gross hematuria. Conclusions: Metal stents are well tolerated by patients with ureteral obstruction of various etiologies and provide a significant financial benefit compared to polymer ureteral stents. For patients not fit for surgical intervention regarding their ureteral occlusive disease, the metal Resonance stent is a financially advantageous and well-tolerated option.
Eric Taylor; Aaron D Benson; Bradley F Schwartz
Related Documents :
10852265 - Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy.
15009295 - Topical class i corticosteroids in 10 patients with bullous pemphigoid: correlation of ...
20581335 - Change in natural history of duchenne muscular dystrophy with long-term corticosteroid ...
12560225 - Efficacy and safety of rituximab in type ii mixed cryoglobulinemia.
2179845 - Treatment of pseudomonas meningitis with ceftazidime with or without concurrent therapy.
14986225 - Sclerosant extravasation as a complication of sclerosing endotherapy for bleeding gastr...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-23
Journal Detail:
Title:  Journal of endourology / Endourological Society     Volume:  -     ISSN:  1557-900X     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8807503     Medline TA:  J Endourol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Southern Illinois University, Urology, 301 N 8th St, # 4B143, springfield, Illinois, United States, 62701-1041, 2175458860;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Trans-?-xylosidase and trans-?-galactosidase activities, widespread in plants, modify and stabilize ...
Next Document:  Knowledge and attitudes of Polish university students toward organ donation and transplantation.